25 May, 2020 17:31
The World Health Organization has paused the clinical trials of anti-malarial drug hydroxychloroquine in coronavirus patients. It says the drug, notably taken and endorsed by US President Donald Trump, has raised safety concerns.
The drug’s safety data is being reviewed by a monitoring board, and the trials have been put on hold, the WHO chief Tedros Adhanom Ghebreyesus told reporters. It was being tested as part of the Solidarity international program aimed at tackling the Covid-19 pandemic.
The UN heath body took the step out of “abundance of caution,” said Mike Ryan, the head of the organization’s emergencies program.
DETAILS TO FOLLOW